SCHEMBL15344006

SCHEMBL15344006

Cc1cc(Cl)c2[nH]c(C(=O)O)cc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 3/20 0.59
PIN1 Q13526 1/20 0.51
HPGD P15428 3/20 0.46
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 1/20 0.46
DAO P14920 2/20 0.46
XDH P47989 1/20 0.45
GPR35 Q9HC97 2/20 0.44
F7 P08709 1/20 0.44
F3 P13726 1/20 0.44
HSD17B10 Q99714 2/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
KMT2A Q03164 1/20 0.42
ALOX15 P16050 1/20 0.42
NFKB1 P19838 1/20 0.42
BLM P54132 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
EIF4A3 P38919 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17920327 0.86 HRH4 (0.59) HRH4PIN1HPGDALDH1A1KDM4E
SCHEMBL3543391 0.83 DAO (0.46) HRH4HPGDALDH1A1KDM4ELMNA
SCHEMBL3274871 0.82 HRH4 (0.56) HRH4HPGDALDH1A1KDM4ELMNA
SCHEMBL3534704 0.82 DAO (0.49) HRH4HPGDALDH1A1KDM4ELMNA
SCHEMBL3095919 0.82 HRH4 (0.57) HRH4PIN1HPGDALDH1A1KDM4E
SCHEMBL15344050 0.82 HRH4 (0.56) HRH4ALDH1A1XDHSYK
SCHEMBL27519330 0.81 SMAD3 (0.50) HRH4HPGDALDH1A1KDM4ELMNA
SCHEMBL3089645 0.81 HPGD (0.53) HRH4HPGDALDH1A1KDM4ELMNA
SCHEMBL4046142 0.80 RAB9A (0.57) HRH4HPGDALDH1A1KDM4ELMNA
SCHEMBL3708783 0.79 XDH (0.69) HRH4PIN1HPGDALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096579-B2 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-08-04 US disclosed
US-20130281430-A1 Amino-Indolyl-Substituted Imidazolyl-Pyrimidines and Their Use as Medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-10-24 US disclosed
CN-1277828-C Piperzine devivs. HOFFMANN LA ROCHE (CH) 2006-10-04 CN disclosed
CN-1245405-C Piperazine derivatives HOFFMANN LA ROCHE (CH) 2006-03-15 CN disclosed
CN-1529706-A Piperazine derivatives - 2004-09-15 CN disclosed
CN-1452622-A Piperzine devivs. HOFFMANN LA ROCHE (CH) 2003-10-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281430-A1 Amino-Indolyl-Substituted Imidazolyl-Pyrimidines and Their Use as Medicaments INMT, IDO1, CHRM1 HRH4 20/4885PIN1 266/4885HPGD 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.